- Home
- GOVX vs EDTK Comparison
GOVX vs EDTK Comparison
Compare GOVX & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- EDTK
- Stock Information
- Founded
- GOVX 2001
- EDTK 2013
- Country
- GOVX United States
- EDTK China
- Employees
- GOVX N/A
- EDTK N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- EDTK Other Consumer Services
- Sector
- GOVX Health Care
- EDTK Real Estate
- Exchange
- GOVX Nasdaq
- EDTK Nasdaq
- Market Cap
- GOVX 15.5M
- EDTK 14.7M
- IPO Year
- GOVX N/A
- EDTK 2020
- Fundamental
- Price
- GOVX $0.44
- EDTK $0.82
- Analyst Decision
- GOVX Strong Buy
- EDTK
- Analyst Count
- GOVX 5
- EDTK 0
- Target Price
- GOVX $12.40
- EDTK N/A
- AVG Volume (30 Days)
- GOVX 2.4M
- EDTK 6.8K
- Earning Date
- GOVX 08-05-2025
- EDTK 08-18-2025
- Dividend Yield
- GOVX N/A
- EDTK N/A
- EPS Growth
- GOVX N/A
- EDTK N/A
- EPS
- GOVX N/A
- EDTK N/A
- Revenue
- GOVX $5,591,576.00
- EDTK $624,365.00
- Revenue This Year
- GOVX N/A
- EDTK N/A
- Revenue Next Year
- GOVX N/A
- EDTK N/A
- P/E Ratio
- GOVX N/A
- EDTK N/A
- Revenue Growth
- GOVX N/A
- EDTK N/A
- 52 Week Low
- GOVX $0.43
- EDTK $0.80
- 52 Week High
- GOVX $11.18
- EDTK $1.27
- Technical
- Relative Strength Index (RSI)
- GOVX 29.07
- EDTK 37.40
- Support Level
- GOVX $0.85
- EDTK $0.85
- Resistance Level
- GOVX $0.98
- EDTK $0.95
- Average True Range (ATR)
- GOVX 0.15
- EDTK 0.06
- MACD
- GOVX -0.04
- EDTK -0.01
- Stochastic Oscillator
- GOVX 5.54
- EDTK 0.00
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.